Terex, Amgen Shine as Post Faces Sales Decline
Two stocks stand out for their potential to continue growing in the market: Terex and Amgen. Terex, founded as a dump truck company, has increased its market share over the last five years with an impressive 14.1% annual revenue growth.
The company's projected revenue growth of 27.6% for the next 12 months is above its two-year trend, indicating accelerating demand.
Amgen, a biotechnology company founded in 1980, boasts a strong financial position with a revenue base of $38.1 billion and an industry-leading return on capital of 17.3%.
On the other hand, Post is considered a stock to sell due to its projected decline in sales by 5.9% over the next 12 months.